FLUKA CHEMICAL CORP -- ETHYLENE GLYCOL ANTI-FREEZING AGENT, 03770 -- 6810-00N092444
=====================  Product Identification  =====================

Product ID:ETHYLENE GLYCOL ANTI-FREEZING AGENT, 03770
MSDS Date:07/01/1999
FSC:6810
NIIN:00N092444
Status Code:A
=== Responsible Party ===
Company Name:FLUKA CHEMICAL CORP
Address:1001 WEST ST PAUL
City:MILWAUKEE
State:WI
ZIP:53233
Country:US
Info Phone Num:414-273-3850
Emergency Phone Num:414-273-3850
CAGE:63181
=== Contractor Identification ===
Company Name:FLUKA CHEMICAL CORP
Address:1001 WEST ST PAUL
Box:City:MILWAUKEE
State:WI
ZIP:53233
Country:US
Phone:414-273-3850
CAGE:63181

=============  Composition/Information on Ingredients  =============

Ingred Name:ETHYLENE GLYCOL  LD50: (ORAL, RAT) 4700 MG/KG
CAS:107-21-1
RTECS #:KW2975000
= Wt:100.
ACGIH STEL:C127 MG/M3;C50 PPM
EPA Rpt Qty:1 LB
DOT Rpt Qty:1 LB

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:SEE INGREDIENT
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:ACUTE EFTS: HARMFUL IF SWALLOWED. MAY
    BE HARMFUL IF INHALED. MAY BE HARMFUL IF ABSORBED THRU SKIN.
    VAP/MIST IS IRRIT TO EYES, MUC MEMBS & UPPER RESP TRACT. CAUSES
    SKIN IRRIT. MAY CAUSE NERVOUS SYSTEM  DISTURBS. EXPOS CAN CAUSE
    NAUS, HDCH & VOMIT. CHRONIC EFTS: POSSIBLE RISK OF CONGENITAL
    MALFORMATION IN FETUS. OVEREXP MAY CAUSE REPRO DISORDER(S) BASED ON
    TESTS W/LAB ANIMALS. TARGET ORGANS: CNS, KID NEYS, EYES, CVS,
    LIVER. ADDNL INFO: WHEN INGESTED EARLY SYMPS MIMIC ALCOHOL
    INEBRIATION & ARE FOLLOWED BY NAUS, VOMIT, ABDOMINAL PAIN,
    WEAKNESS, MUSCLE TENDERNESS, RESP FAILURE, CONVULSIONS, CVS COLLA
    PSE, PULM EDEMA, (EFTS OF OVEREXP)
Effects of Overexposure:HLTH HAZS: HYPOCALCEMIC TETANY & SEV METABOLIC
    ACIDOSIS. W/OUT TREATMENT, DEATH MAY OCCUR IN 8 TO 24 HRS. VICTIMS
    WHO SURVIVE INITIAL TOXICITY PERIOD USUALLY DEVELOP RENAL FAILURE
    ALONG W/BRAIN & LIVE R DAMAGE. ETHYLENE GLYCOL IS METABOLIZED TO
    GLYCOALDEHYDE, GLYCOLIC ACID & GLYOXAL, FOLLOWED BY CONVERSION TO
    GLYCOXYLIC ACID, FORMIC ACID & OXALIC ACID. IT HAS BEEN SHOWN THAT
    ETHYLENE GLYCOL IS MUCH  LESS TOXIC THAN ITS METABOLITES. GLYCOLIC
    ACID IS THOUGHT TO BE THE MAJOR TOXIC METABOLITE CAUSING ACUTE AS
    WELL AS REPRO & DEVELOPMENTAL TOXICITY OBSERVED W/ETHYLENE GLYCOL
    EXPOSURES. ASLO, SEE TOXI COLOGICAL INFO.

=======================  First Aid Measures  =======================

First Aid:EYES: IN CASE OF CONTACT, IMMEDIATELY FLUSH EYES WITH COPIOUS
    AMOUNTS OF WATER FOR AT LEAST 15 MINUTES. SKIN: IN CASE OF CONTACT,
    IMMEDIATELY FLUSH SKIN WITH COPIOUS AMOUNTS OF WATER FOR AT LEAST
    15 M INUTES WHILE REMOVING CONTAMINATED CLOTHING AND SHOES.
    INHALATION: REMOVE TO FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL
    RESPIRATION. IF BREATHING IS DIFFICULT, GIVE OXYGEN. INGESTION: IF
    SWALLOWED, W ASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS.
    CALL A PHYSICIAN. WASH CONTAMINATED CLOTHING BEFORE REUSE.

=====================  Fire Fighting Measures  =====================

Flash Point:=111.C, 231.8F
Autoignition Temp:=400.C, 752.F
Lower Limits:3.2%
Upper Limits:15.3%
Extinguishing Media:WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL POWDER OR
    APPROPRIATE FOAM.
Fire Fighting Procedures:USE NIOSH APPROVED SCBA AND FULL PROTECTIVE
    EQUIPMENT  TO PREVENT CONTACT WITH SKIN AND EYES.
Unusual Fire/Explosion Hazard:EMITS TOXIC FUMES UNDER FIRE CONDITIONS.

==================  Accidental Release Measures  ==================

Spill Release Procedures:WEAR NIOSH APPROVED RESPIRATOR, CHEMICAL
    SAFETY GOGGLES, RUBBER BOOTS AND HEAVY RUBBER GLOVES. ABSORB ON
    SAND OR VERMICULITE AND PLACE IN CLOSED CONTAINERS FOR DISPOSAL.
    VENTILATE AREA AND WASH SPILL  SITE AFTER MATERIAL PICKUP IS
    COMPLETE.

======================	Handling and Storage  ======================

Handling and Storage Precautions:DO NOT BREATHE VAPOR. DO NOT GET IN
    EYES, ON SKIN, ON CLOTHING. AVOID PROLONGED OR REPEATED EXPOSURE.
    WASH THOROUGHLY AFTER HANDLING. KEEP TIGHTLY CLOSED. STORE IN A
    COOL, DRY PLACE.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:WEAR APPROPRIATE NIOSH APPROVED RESPIRATOR.
Ventilation:MECHANICAL EXHAUST REQUIRED.
Protective Gloves:CHEMICAL-RESISTANT GLOVES.
Eye Protection:ANSI APPROVED CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:ANSI APPROVED EYE WASH AND DELUGE SHOWER .
    WEAR OTHER PROTECTIVE CLOTHING.
Supplemental Safety and Health
STATE REG INFO: SUBMISSION (TSCATS) DATA BASE, DEC 1998. NIOSH
    ANALYTICAL METHOD, 1994:ETHYLENE GLYCOL, 5500. NIOSH ANALYTICAL
    METHOD, 1996: GLYCOLS, 5523. NTP CARCINOGENESIS STUDIES (FEED); NO
    EVIDEN CE:MOUSE.NTPTR NTP-TR-413,93.

==================  Physical/Chemical Properties  ==================

Vapor Pres:0.08 MM 20 C
Vapor Density:2.1
Spec Gravity:1.124
Appearance and Odor:VISCOUS, COLORLESS LIQUID.

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
STRONG ACIDS, STRONG OXIDIZING AGENTS, STRONG BASES.
Stability Condition to Avoid:HEAT. PROTECT FROM MOISTURE.
Hazardous Decomposition Products:TOXIC FUMES OF CARBON MONOXIDE, CARBON
    DIOXIDE.

===================  Toxicological Information	===================

Toxicological Information:ETHYLENE GLYCOL RTECS #: KW2975000: IRRIT
    DATA: EYE-RAT 12 MG/M3/3D TXAPA9 16,646,1970. SKN-RBT 555 MG OPEN
    MLD UCDS 7/21/1965. EYE RBT 500 MG/24H MLD 85JCAE -,205,1986.
    EYE-RBT 100 MG/1H MLD NTIS LMF -69. EYE-RBT 12 MG/M3 3D TXAPA9
    16,646,1970. EYE-RBT 1440 MG/6H MOD BUYRAI 31,25,1977. TOXICITY
    DATA: ORL-HMN LDLO:786 MG/KG EJTAXAZ. ORL-HMN LD50:398 MG/KG.
    SMEZA5 26(2), 48,1983. UNR-MAN LDLO:1637 G M/KG 85DCAI 2,73,1970.
    ORL-RAT LD50:4700 MG/KG GTPZAB 26(6), 28, 1982. IPR-RAT LD50:5010
    MG/KG KRKRDT 9,36,1981. SCU-RAT LD50:2800 MG/KG. KRKRDT 9,36,1981.
    IVN-RAT LD50:3260 MG/KG KRKRDT 9,36,1981.UNR -RAT LD50:13 G/KG
    (ECOLOGICAL INFO)

=====================  Ecological Information  =====================

Ecological:DATA NOT YET AVAILABLE. --TOXICOLOGICAL INFO: GISAAA
    33(3),16,1968. ORL-MUS LD50:5500 MG/KG GISAAA 32(3),31,1967.
    IPR-MUS LD50:5614 MG/KG FEPRA7 6,342,1947. IVN-MUS LD50:3 G/KG
    JPETAB 65,89,1939. UNR- MUS LD50:8050 GM/KG GISAAA 33(3), 16,1968.
    ORL-DOG LD50:5500 MG/KG RMVEAG 154,173,1978. ORL-CAT LD50:1650
    MG/KG RMVEAG 154,137,1978. ORL-CAT LD50:1650 MG/KG RMVEAG154,
    173,1978. SKN-RBT LD50:9530 UL/K G 34ZIAG -, 731, 1968.UNR-RBT
    LD50: 5017 MG/KG GISAAA 33(3), 16, 1968. ORL-GPG LD50:6610 MG/KG
    JIHTAB 23,259,1941. UNR-GPG LD50:11150 MG/KG GISAAA 3393),16,1968.
    TARGET ORGAN DATA: PERIPHERAL NERVE &  SENSATION (TRANSPORT INFO)

====================  Disposal Considerations  ====================

Waste Disposal Methods:DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE
    SOLVENT AND BURN IN A CHEMICAL INCINERATOR EQUIPPED WITH AN
    AFTERBURNER AND SCRUBBER. OBSERVE ALL FEDERAL, STATE AND LOCAL
    ENVIRONMENTAL REGULATIONS.

===================  MSDS Transport Information  ===================

Transport Information:CONTACT FLUKA CHEMICAL COMPANY FOR TRANSPORATION
    INFORMATION. --ECOLOGICAL INFO: (SENSORY CHANGE INVOLVING
    PERIPHERAL NERVE. BEHAVIORAL (CONVULSIONS OR EFT ON SEIZURE
    THRESHOLD; MUSCLE WEAK; COMA; HEA DACHE). GASTROINTESTINAL
    (HYPERMOTILITY, DIARR; NAUSEA OR VOMITING). LIVER (OTHER CHANGES).
    ENDOCRINE (HYPOGLYCEMIA). BLOOD (OTHER CHANGES). ONLY SELECTED
    REGISTRY OF TOXIC EFFECTS OF CHEMICAL SUBSTAN CES (RTECS) DATA IS
    PRESENTED HERE. SEE ACTUAL ENTRY IN RTECS FOR COMPLETE INFO.

=====================  Regulatory Information  =====================

SARA Title III Information:THIS PROD IS SUBJECT TO SARA SECTION 313
    REPORTING REQS. --OTHER INFO: 100 MG/M3 DTLVS TLV/BEI, 1997. EPA
    FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION/RE-REGISTRATION FEREAC
    54,7440,1989. MSHA STD-AIR :TWA 10 MG/M3 (PARTICULATE) DTLWS
    3,19,1973. OEL-AUSTRALIA:TWA 60 MG/M3; STEL 120 MG/M3 JAN 1993.
    OEL-BELGIUM:STEL 50 PPM (127 MG/M3) JAN 1993. OEL-DENMARK:STEL 50
    PPM (130 MG/M3) JAN 1993. OEL-DENMAR K:TWA 10 MG/M3 JAN 1993.
    OEL-FINLAND:TWA 10 MG/M3; STEL 20 MG/M3 JAN 1993. OEL-FINLAND:TWA
    50 PPM (125 MG/M3); STEL 75 PPM (190 MG/M3) JAN 1993.
    OEL-FRANCE:STEL 50 PPM (125 MG/M3) JAN 1993. OEL-HUNGAR Y:STEL 50
    MG/M3; SKIN JAN (FED REG INFO)
Federal Regulatory Information:EUROPEAN INFO - EC INDEX NO:
    603-027-00-1. HARMFUL. R 22 HARMFUL IF SWALLOWED. --SARA REG INFO:
    1993. OEL-THE NETHERLANDS:TWA 10 MG/M3 JAN 1993. OEL-THE
    NETHERLANDS:TWA 50 PPM (125 MG/M3) JAN 1993. OE L-RUSSIA:STEL 5
    MG/M3 JAN 1993. OEL-SWEDEN:TWA 50 PPM (130 MG/M3); STEL 75 PPM
    (190MG/M3) JAN 1993. OEL-SWITZERLAND:TWA 1 MG/M3 JAN 1993.
    OEL-SWITZERLAND:TWA 50 PPM (125 MG/M3) JAN 1993. OEL-UNITED KI
    NGDOM:TWA 10 MG/M3 JAN 1993. OEL-UNITED KINGDOM:TWA 60 MG/M3; STEL
    125 MG/M3 JAN 1993. OEL IN BULGAR IA, COLOMBIA, JORDAN, KOREA CHECK
    ACGIH TLV. OEL IN NEW ZEALAND, SINGAPORE, VIETNAM CHECK ACGIH TLV.
    NOHS 1974:HZD 32385; NIS (ST REG INFO)
State Regulatory Information:N/P. --FED REG INFO: 208; TNF 69314; NOS
    174; TNE 743782. NOES 1983: HZD 32385; NIS 340; TNF 102395; NOS
    214; TNE 1511087; TFE 446607. EPA GENETOX PROGRAM 1988, NEGATIVE:
    CELL TRANSFORM.-SA7/SHE; N CR ASSA-ANEUPLOIDY. EPA GENETOX PROGRAM
    1988, NEGATIVE: HISTIDINE REVERSION-AMES TEST. EPA GENTOX PROGRAM
    1988, INCONCLUSIVE: D MELANOGASTER-WHOLE SEX CHROM LOSS. EPA
    GENETOX PROGRAM 1988, INCONCLUSIVE:  D MELANOGASTER-NONDISJUNCTION.
    EPA TSCA SECTION 8(B) CHEM INVENTORY. EPA TSCA SECTION 8(D)
    UNPUBLISH ED HLTH/SFTY STUDIES. EPA TSCA SECTION 8(E) RISK
    NOTIFICATION, 8EHQ-0892-9100; 8EHQ-0892-9252 ON EPA IRIS DATABASE.
    EPA TACA TEST (SUPDAT)

=======================  Other Information  =======================

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.